These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25214527)

  • 41. Reduced creatine kinase release with statin use at the time of myocardial infarction.
    Bybee KA; Kopecky SL; Williams BA; Murphy JG; Scott Wright R
    Int J Cardiol; 2004 Sep; 96(3):461-6. PubMed ID: 15301900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Approach to clinical and genetic characterization of statin-induced myopathy.
    Feng Q
    Methods Mol Biol; 2014; 1175():67-90. PubMed ID: 25150867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fast skeletal troponin I, but not the slow isoform, is increased in patients under statin therapy: a pilot study.
    Trentini A; Spadaro S; Rosta V; Manfrinato MC; Cervellati C; Dalla Corte F; Hanau S; Volta CA; Bellini T
    Biochem Med (Zagreb); 2019 Feb; 29(1):010703. PubMed ID: 30591813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are statin medications safe in patients with ALS?
    Zinman L; Sadeghi R; Gawel M; Patton D; Kiss A
    Amyotroph Lateral Scler; 2008 Aug; 9(4):223-8. PubMed ID: 18608105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic creatine kinase elevation not associated with HMG-CoA reductase inhibitor treatment.
    Lin JC; Ito MK
    Ann Pharmacother; 1999 Feb; 33(2):163-6. PubMed ID: 10084410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of sequence variants in CKM (creatine kinase, muscle) and COX4I2 (cytochrome c oxidase, subunit 4, isoform 2) genes with racing performance in Thoroughbred horses.
    Gu J; MacHugh DE; McGivney BA; Park SD; Katz LM; Hill EW
    Equine Vet J Suppl; 2010 Nov; (38):569-75. PubMed ID: 21059062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myotoxicity associated with lipid-lowering drugs.
    Baer AN; Wortmann RL
    Curr Opin Rheumatol; 2007 Jan; 19(1):67-73. PubMed ID: 17143099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statin-induced Ca(2+) release was increased in B lymphocytes in patients who showed elevated serum creatine kinase during statin treatment.
    Hattori T; Saito K; Takemura M; Ito H; Ohta H; Wada H; Sei Y; Kawamura M; Seishima M
    J Atheroscler Thromb; 2009; 16(6):870-7. PubMed ID: 20032581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Approach to the patient who is intolerant of statin therapy.
    Eckel RH
    J Clin Endocrinol Metab; 2010 May; 95(5):2015-22. PubMed ID: 20444930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Rhabdomyolysis related to statin and seizures: report of 3 cases].
    Guan YQ; Shi YJ; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1795-6. PubMed ID: 22027795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced risks of death and CHF are associated with statin therapy administered acutely within the first 24 h of AMI.
    Wright RS; Bybee K; Miller WL; Laudon DA; Murphy JG; Jaffe AS
    Int J Cardiol; 2006 Apr; 108(3):314-9. PubMed ID: 15975672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The cholesterol-lowering effect of statins is modified by
    Tornio A; Bigossi M; Siddiqui MK; Kennedy G; Melhem A; Chourasia MK; Maroteau C; Pola R; Chasman DI; Doney ASF; Palmer CNA
    Front Pharmacol; 2023; 14():1090010. PubMed ID: 36998609
    [No Abstract]   [Full Text] [Related]  

  • 53. [Muscle problems due to statins: underestimated].
    Janssen SP; Smulders YM; Gerdes VE; Visseren FL
    Ned Tijdschr Geneeskd; 2010; 154():A1684. PubMed ID: 21435278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of HMG-CoA reductase inhibitors on blood pressure in hypertensive patients treated with blood pressure-lowering agents: retrospective study using an anti-hypertensive drug database.
    Hashimoto S; Urushihara H; Hinotsu S; Kosugi S; Kawakami K
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):235-41. PubMed ID: 22428476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statin-Associated Myalgias and Muscle Injury-Recognizing and Managing Both While Still Lowering the Low-Density Lipoprotein.
    Mammen AL
    Med Clin North Am; 2021 Mar; 105(2):263-272. PubMed ID: 33589101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incremental lowering of low-density lipoprotein cholesterol with ezetimibe 20 mg vs 10 mg daily in patients receiving concomitant statin therapy.
    Ziada A; Schwarz UI; DeGorter MK; Tirona RG; Ban MR; Kim RB; Hegele RA
    Can J Cardiol; 2013 Nov; 29(11):1395-9. PubMed ID: 24182755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of statin dosing intensity on transaminase and creatine kinase.
    Dale KM; White CM; Henyan NN; Kluger J; Coleman CI
    Am J Med; 2007 Aug; 120(8):706-12. PubMed ID: 17679130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigation of predictors of increased creatine kinase levels following vascular surgery and the association with peri-operative statin therapy.
    Biccard BM
    Cardiovasc J Afr; 2009; 20(3):187-91. PubMed ID: 19575084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.
    Chu AY; Guilianini F; Grallert H; Dupuis J; Ballantyne CM; Barratt BJ; Nyberg F; Chasman DI; Ridker PM
    Circ Cardiovasc Genet; 2012 Dec; 5(6):676-85. PubMed ID: 23118302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.